Ligand · ODO
ODO · 4-[(E)-C-methyl-N-oxidanyl-carbonimidoyl]benzene-1,3-diol
ODO, 4-[(E)-C-methyl-N-oxidanyl-carbonimidoyl]benzene-1,3-diol (C8 H9 N O3, 167.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds…
- Component
- ODO
- Formula
- C8 H9 N O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
ODO in 2 structures; the first of them:
- 4BDB · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · ODO A1515 · binds LEU226, VAL234, ALA247, ILE286, LEU301, GLU302, LEU303, MET304 and 3 more
- 4BDB · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · ODO A1515 · binds LEU226, VAL234, ALA247, ILE286, LEU301, GLU302, LEU303, MET304 and 3 more
Residues it binds most
LEU 2, ALA 2, GLU 2, GLY 2, ILE 2, MET 2, THR 2, VAL 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.